Sodium Channel Blocker Shows Promise As A Potential Treatment For Cystic Fibrosis
Cystic fibrosis patients may benefit from a new therapy that increases airway hydration, preventing the buildup of mucous, which is a key factor in the disease, according to researchers at Parion Sciences in Durham, N.C. The research was presented on Sunday, May 17, during the American Thoracic Society’s 105th International Conference in San Diego.
More: continued here
Filed under: Clinical Trials on May 18th, 2009
You must be logged in to post a comment.